A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V
1. Canadian Blood Services, Research and Development;2. Pathology and Laboratory Medicine;3. Centre for Blood Research;4. Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada. E‐mail: ed.pryzdial@blood.ca